Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;26(5):511-9.
doi: 10.1097/YCO.0b013e3283642cb6.

Assessing prescription stimulant use, misuse, and diversion among youth 10-18 years of age

Linda B Cottler  1 , Catherine W Striley, Sonam O Lasopa
Affiliations
Review

Assessing prescription stimulant use, misuse, and diversion among youth 10-18 years of age

Linda B Cottler et al. Curr Opin Psychiatry. 2013 Sep.

Abstract

Purpose of review: Assessing the medical and nonmedical use (NMU) of stimulants and diversion is a challenge, especially among youth, with different methods for recruitment and definitions of NMU. The field needs inexpensive, yet effective and reliable, methods of data collection to understand the prescription drug use problem. Most studies of youth are school or web-based, and conducted with teens.

Recent findings: The National Monitoring of Adolescent Prescription Stimulants Study recruited 11,048 youth 10-18 years of age from urban, rural, and suburban areas in 10 US cities using an entertainment venue intercept study. This review discusses the effectiveness of the method and results from four cross-sections as well as the representativeness of the sample. Lifetime prevalence of any stimulant use was 14.8%, with rates highest among rural 16-18 year olds. The rate of last 30-day use was 7.3%, with over half (3.9%) NMU. Nearly 12% of all youth (whether a user or not) reported lifetime incoming/outgoing diversion of prescription stimulants.

Summary: Because no study has focused on stimulant use among youth as young as 10 and 11, this study is a landmark for future comparisons and offers a unique strategy for sampling and data collection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

Authors declare no conflicts of interest other than those in the acknowledgements.

Figures

Figure 1
Figure 1
Accrual of the N-MAPSS sample from 21,444 approached to 11,048 completed
See this image and copyright information in PMC

References

    1. Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alc Dependence. 2006;83(1):4–7. - PubMed
    1. Barrett SP, Meisner JR, Stewart SH. What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations. Curr Drug Abuse Rev. 2008;1:255–62. - PubMed
    1. Denisco RA, Chandler RK, Compton WM. Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clinical Psychopharm. 2008;16(5):417–28. - PMC - PubMed
    1. Substance Abuse and Mental Health Services Administration. National survey on drug use and health: National Findings. Rockville, MD: Department of Health and Human Services, Office of Applied Studies; 2007. (Contract No: DHHS publication No. SMA 08-4343). DoHaH; 2008.
    1. Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2003 National survey on drug use and health. Department of Health and Human Services, Office of Applied Studies; Rockville, MD: 2004.

Substances